Healthcare Industry News: hematology analyzer
News Release - October 24, 2007
Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract ExtensionTechnical Merit and Pricing Key Factors
MUNDELEIN, Ill., Oct. 24 (HSMN NewsFeed) -- Sysmex America, Inc. today announced that the company has been awarded a hematology contract extension by group purchasing organization MedAssets Supply Chain Systems. The extension agreement provides MedAssets' customers access to Sysmex hematology analyzers, reagents, consumables and services effective October 1, 2007, said John Kershaw, President, Sysmex America, Inc. Training and technical support for the organization's members will be provided through the company's U.S. headquarters in Mundelein. This contract extends the original contract between the companies that originated in April 2004.
"MedAssets Supply Chain Systems awards contracts to companies based on extensive criteria including product quality and customer service. Sysmex America's proven performance with our customers during the past three years, including an award in MedAssets' first ever Group Buy Initiative for hematology, merits the extension of the company's contract. Sysmex's offer of exceptional value through this program underscores their commitment to our customer base," said Mary Ellen Kimmeth, Vice President, Laboratory & Capital Equipment Services, MedAssets Supply Chain Systems.
"We at Sysmex America are pleased that MedAssets and its customers will retain its working relationship with our company. Their access to reliable and proven Sysmex hematology analyzers will serve them well as they seek greater efficiency and effectiveness in an increasingly challenging healthcare environment," said Kershaw.
Sysmex hematology products included in the MedAssets contract agreement range from the pocH-100i(TM) and the KX-21N(TM) for small laboratories to the fully automated XE-Alpha N(TM) and HST-N(TM) Integrated Hematology Systems with automated slide preparation capabilities. Also included are the Sysmex® XE-Series Automated hematology analyzers, the Sysmex XT-Series Automated hematology analyzers and the Sysmex XS-Series Automated hematology analyzers, all of which use the same fluorescent flow technology platform, user interface, and reagents and controls, leading to improved laboratory standardization.
Sysmex hematology analyzers have been ranked as the industry's best in reliability and performance for eight consecutive years by the IMVServiceTrak(TM) survey. IMVServiceTrak(TM), conducted by an independent research company that analyzes science-based instrument industries, surveyed more than 1,600 randomly chosen clinical laboratory health care professionals from varying hospital sizes across the country.
MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, including 2,500 hospitals and 30,000 non-acute care healthcare providers. For more information, go to http://www.medassets.com.
About Sysmex America, Inc.
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 35 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit http://www.sysmex.com/usa.
Source: Sysmex America
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.